ID   TPA1-41
AC   CVCL_XA82
SY   TPA 1-41
DR   CCRID; 4201PAT-CCTCC00059
DR   JCRB; IFO50178
DR   Wikidata; Q98133512
RX   DOI=10.1038/nbt1189-1163;
RX   Patent=US5496549;
RX   Patent=US5506135;
RX   PubMed=1713912;
RX   PubMed=2107601;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2085.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Discontinued: JCRB; IFO50178; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
RX   DOI=10.1038/nbt1189-1163;
RA   Kurokawa T., Iwasa S., Kakinuma A.;
RT   "Enhanced fibrinolysis by a bispecific monoclonal antibody reactive to
RT   fibrin and tissue plasminogen activator.";
RL   Biotechnology (N.Y.) 7:1163-1167(1989).
//
RX   Patent=US5496549;
RA   Yamazaki H., Tanoue K., Iwasa S., Kurokawa T.;
RT   "Bispecific monoclonal antibodies, thrombolytic agent
RT   and method of cell lysis.";
RL   Patent number US5496549, 05-Mar-1996.
//
RX   Patent=US5506135;
RA   Iwasa S., Kurokawa T., Toyoda Y.;
RT   "Hybrid monoclonal antibodies, their production and use.";
RL   Patent number US5506135, 09-Apr-1996.
//
RX   PubMed=1713912; DOI=10.1093/oxfordjournals.jbchem.a123364;
RA   Kurokawa T., Toyoda Y., Iwasa S.;
RT   "Characterization of monoclonal antibodies against human tissue
RT   plasminogen activator (tPA): quantitation of free tPA in human cell
RT   cultures by an ELISA.";
RL   J. Biochem. 109:217-222(1991).
//
RX   PubMed=2107601; DOI=10.1016/0049-3848(90)90382-M;
RA   Kurokawa T., Iwasa S., Kakinuma A.;
RT   "Enhancement of fibrinolysis by bispecific monoclonal antibodies
RT   reactive to fibrin and plasminogen activators.";
RL   Thromb. Res. 47 Suppl. 10:83-89(1990).
//